Skip to main content
. 2010;12(2):PCC.09m00799. doi: 10.4088/PCC.09m00799gry

Table 1.

Background Characteristics of 100 Psychotic Patients by Treatment Groupa

Characteristic Haloperidol (n = 23) Risperidone (n = 52) Olanzapine (n = 25) χ22 or F2 P
Age, y 30.0 ± 12.7 29.9 ± 9.5 30.8 ± 12.2 0.26 .769
Gender, male, n (%) 13 (56) 34 (65) 19 (76) 2.04 .360
Civil status, never married, n (%) 19 (83) 40 (77) 20 (80) 0.33 .848
Education, y 11.3 ± 3.8 10.4 ± 3.5 9.6 ± 1.9 1.64 .198
Age at first psychotic symptom, y 26.4 ± 10.2 26.1 ± 8.5 26.8 ± 11.8 0.39 .962
CASH domain
 Reality-distortion 4.21 ± 0.85 3.98 ± 0.93 3.52 ± 1.12 3.31 .041b
 Disorganization 2.08 ± 1.53 1.92 ± 1.78 2.08 ± 1.32 0.12 .885
 Negative 1.65 ± 1.33 1.50 ± 1.56 2.24 ± 1.66 1.97 .145
Diagnosis, schizophrenia, n (%) 11 (48) 26 (50) 14 (56) 0.36 .834
Any psychotropic drug at admission, n (%) 3 (13) 5 (10) 3 (12) 0.25 .961
a

Values are mean ± SD unless otherwise specified.

b

Haloperidol > olanzapine.

Abbreviation: CASH = Comprehensive Assessment of Symptoms and History.